Literature DB >> 32324980

The Association of Multiparity with Lung Function and Chronic Obstructive Pulmonary Disease-Related Phenotypes.

Matthew Moll1,2, Elizabeth A Regan3, John E Hokanson4, Sharon M Lutz5, Edwin K Silverman1,2,6, James D Crapo7, Barry J Make7, Dawn L DeMeo1,2.   

Abstract

BACKGROUND: Apparent increased female susceptibility to chronic obstructive pulmonary disease (COPD) suggests sex hormones modulate disease pathogenesis. Little is known about associations between multiparity and lung function in smokers. RESEARCH QUESTION: We hypothesized that multiparity is associated with lung function and measures of emphysema and airway disease. STUDY DESIGN AND METHODS: Utilizing female participants from the 5-year follow up of the COPD Genetic Epidemiology (COPDGene®) study we performed multivariable linear regressions to assess the effect of multiparity and number of pregnancies on forced expiratory volume in 1 second (FEV1) percentage of predicted (% predicted), FEV1/forced vital capacity (FVC), percent emphysema on computed tomography (CT) scans, and Pi10, a measure of airway thickening. We sampled never smokers and those with lower smoking exposure from the National Health and Nutrition Examination Survey (NHANES) 2011-2012 dataset.
RESULTS: We included 1820 participants from COPDGene® and 418 participants from NHANES (321 never smokers, 97 ever smokers). In COPDGene®, multiparity (beta coefficient [β] = -3.8, 95% confidence interval [CI]: [-6.5, -1.1], p = 0.005) and higher number of pregnancies were associated with lower FEV1 % predicted. Multiparity was not associated with percent emphysema or Pi10. In individuals with no or mild obstruction, multiparity was associated with lower FEV1 % predicted. There was an interaction with multiparity and age on FEV1 % predicted (p = 0.025). In NHANES, there was no association between multiparity and FEV1 % predicted in never smokers or the lower smoking exposure group.
INTERPRETATION: Multiparity was associated with lower FEV1 % predicted in current and former smokers in COPDGene® study participants. These preliminary results emphasize the importance of smoking abstinence in women of child-bearing age. JCOPDF
© 2020.

Entities:  

Keywords:  chronic obstructive pulmonary disease; copd; female; hormones; multiparity; phenotypes; pregnancy

Year:  2020        PMID: 32324980      PMCID: PMC7454017          DOI: 10.15326/jcopdf.7.2.2019.0166

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  49 in total

Review 1.  The Rh blood group system: a review.

Authors:  N D Avent; M E Reid
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

Review 2.  Immunity, thyroid function and pregnancy: molecular mechanisms.

Authors:  Anthony P Weetman
Journal:  Nat Rev Endocrinol       Date:  2010-04-27       Impact factor: 43.330

3.  A mixed phenotype of airway wall thickening and emphysema is associated with dyspnea and hospitalization for chronic obstructive pulmonary disease.

Authors:  Nguyen Van Tho; Emiko Ogawa; Le Thi Huyen Trang; Yasushi Ryujin; Rie Kanda; Hiroaki Nakagawa; Kenichi Goto; Kentaro Fukunaga; Yuichi Higami; Ruriko Seto; Hiroshi Wada; Masafumi Yamaguchi; Taishi Nagao; Le Thi Tuyet Lan; Yasutaka Nakano
Journal:  Ann Am Thorac Soc       Date:  2015-07

4.  Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema.

Authors:  Ming Shan; Xiaoyi Yuan; Li-Zhen Song; Luz Roberts; Nazanin Zarinkamar; Alexander Seryshev; Yiqun Zhang; Susan Hilsenbeck; Seon-Hee Chang; Chen Dong; David B Corry; Farrah Kheradmand
Journal:  Sci Transl Med       Date:  2012-01-18       Impact factor: 17.956

5.  Gender-related differences in severe, early-onset chronic obstructive pulmonary disease.

Authors:  E K Silverman; S T Weiss; J M Drazen; H A Chapman; V Carey; E J Campbell; P Denish; R A Silverman; J C Celedon; J J Reilly; L C Ginns; F E Speizer
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

6.  Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung.

Authors:  Gisle Berge; Steen Mollerup; Steinar ØVrebø; Alan Hewer; David H Phillips; Einar Eilertsen; Aage Haugen
Journal:  Lung Cancer       Date:  2004-09       Impact factor: 5.705

Review 7.  The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism.

Authors:  Sigal Ben-Zaken Cohen; Peter D Paré; S F Paul Man; Don D Sin
Journal:  Am J Respir Crit Care Med       Date:  2007-04-05       Impact factor: 21.405

8.  [Vital capacity and peak expiratory flow rates in a North-African population aged 60 years and over: influence of anthropometric data and parity].

Authors:  H Ben Saad; S Rouatbi; S Raoudha; Z Tabka; C Laouani Kechrid; G Hassen; H Guenard
Journal:  Rev Mal Respir       Date:  2003-09       Impact factor: 0.622

9.  Pregnancy and risk of renal cell cancer: a population-based study in Sweden.

Authors:  Mats Lambe; P Lindblad; J Wuu; R Remler; C-c Hsieh
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

10.  A Report of the Women's Health Congress Workshop on The Health of Women of Color: A Critical Intersection at the Corner of Sex/Gender and Race/Ethnicity.

Authors:  Jennifer L Plank-Bazinet; Susan G Kornstein; Janine Austin Clayton; Worta McCaskill-Stevens; Lauren Wood; Nakela Cook; Salman M Tajuddin; Gina M Brown; Tamara Harris; Michele K Evans; Lisa Begg; Claudette E Brooks; Leah R Miller; Amy Caroline Mistretta; Terri L Cornelison
Journal:  J Womens Health (Larchmt)       Date:  2016-01       Impact factor: 2.681

View more
  2 in total

1.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Sex and Gender Omic Biomarkers in Men and Women With COPD: Considerations for Precision Medicine.

Authors:  Dawn L DeMeo
Journal:  Chest       Date:  2021-03-18       Impact factor: 10.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.